Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115711) titled 'Application of RecistTM criteria in the efficacy evaluation of advanced malignant solid tumors' on Dec. 30, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Army Medical Center of PLA
Condition:
Advanced malignant solid tumor
Intervention:
Gold Standard:Response Evaluation Criteria for Solid Tumors(RECIST V1.1)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Target condition:220;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=30...